Corcept Therapeutics (NASDAQ:CORT) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 6 | 2 | 0 | 0 | 0 |
Last 30D | 1 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 2 | 0 | 0 | 0 | 0 |
3M Ago | 3 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $46.5, along with a high estimate of $65.00 and a low estimate of $35.00. This upward trend is evident, with the current average reflecting a 9.72% increase from the previous average price target of $42.38.
![1722340829_0.png](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240730/41468935-0-83ffa30661c081353d56d8d2e03f3e10.png/big)
Decoding Analyst Ratings: A Detailed Look
An...
ログインすると全部閲覧できます。
ログイン